Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV- 1
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies | PLOS Pathogens
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques | PLOS Pathogens
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques | PLOS Pathogens
BS EN 13707:2013
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection | PLOS Computational Biology
PDF) Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection | PLOS Computational Biology
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques | PLOS Pathogens
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection | PLOS Computational Biology
Role of cytokine agonists and immune checkpoint inhibitors toward HIV remission
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques | PLOS Pathogens
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection | PLOS Computational Biology
Role of cytokine agonists and immune checkpoint inhibitors toward HIV remission
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies | PLOS Pathogens
